---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-025421"
form_type: "8-K"
ticker: "PCSA"
cik: "0001533743"
company_name: "Processa Pharmaceuticals, Inc."
filed_at: "2025-08-25T23:59:59+00:00"
generated_at: "2026-05-17T10:12:45.741017+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Processa Pharmaceuticals changes 2025 Special Meeting location to Pasadena, CA

## Summary
- Board changed 2025 Special Meeting location from Vero Beach, FL to Pasadena, CA (August 25, 2025).
- Original location: 601 21st Street, Suite 300, Vero Beach, FL 32960.
- New location: 594 East Colorado Blvd., Suite 200, Pasadena, CA 91101.

## SEC filing metadata
- accession: 0001641172-25-025421
- form_type: 8-K
- ticker: PCSA
- cik: 0001533743
- company_name: Processa Pharmaceuticals, Inc.
- filed_at: 2025-08-25T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1533743/000164117225025421/0001641172-25-025421-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1533743/000164117225025421/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-025421
- JSON: https://secwatch.observer/filing/0001641172-25-025421.json
- Plain text: https://secwatch.observer/filing/0001641172-25-025421.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.